Park View Elementary School

Skip to main content
Mobile Menu

Welcoming of New Board Members

Welcome Cary Weisgram

Cary Benjamin Weisgram M.Ed. is a learning systems administrator with Start Early, an early childhood education advocacy non-profit that promotes the health and education of children in poverty between 0 and 5 years old. He is father to one current and one future student at Madison Elementary and an active member of Lombard Town Centre and the Helen Plum Library Foundation. He comes to the District 44 Board with the following experience:

  • B.A. in English Secondary Education from The University of Illinois at Chicago, 2005.
  • M.Ed. in Curriculum, Technology, and Education Reform from The University of Illinois at Urbana-Champaign, 2011.
  • Eight years of experience as a high school English Language Arts teacher for Chicago Public Schools and Township District 214.
  • Six years specializing in educational technology for a trade association and now a non-profit.

Cary believes in Constructionism, the idea that learning occurs best when students and adults are able to imagine the world around them and construct new ideas and frameworks by applying their lived experience in new and creative spaces. On the school board, he hopes to apply this philosophy by promoting the expansion of learning space and opportunities in the district technology plan and provide for professional development to support imaginative solutions for all of our kids.
 

Welcome Sarah Novey

Sarah Novey is a former high school science teacher who values high quality public education. She is a mother of two daughters in Kindergarten and 3rd grade at Madison Elementary. Sarah is an active community volunteer serving in both the Madison PTA and as a 3rd grade Girl Scout Troop leader. She has also participated in various district level committees including as a parent representative on the Dual Language committee and on the Superintendent’s Parent Advisory Team. She currently is employed as a Senior Data Team Lead, managing database for clinical trials.